Prostaglandin G2

DB03866ExperimentalSmall molecule

A cyclic endoperoxide intermediate produced by the action of CYCLOOXYGENASE on ARACHIDONIC ACID. It is further converted by a series of specific enzymes to the series 2 prostaglandins. [PubChem].

Mechanism: Pharmacologically active on Prostaglandin G/H synthase 2
Curator reviewed
Formula / weight: C₂₀H₃₂O₆ · 368.4645 g/mol (avg)

Resolves to

Compound

UNIIAZ87DUD2Y8ChEBI27647PubChem5280883KEGGC05956

Structure

InChIKeySGUKUZOVHSFKPH-YNNPMVKQSA-NSMILES[H][C@@](CCCCC)(OO)\C=C\[C@@]1([H])[C@@]2([H])C[C@]([H])(OO2)[C@]1([H])C\C=C/CCCC(O)=O

Targets

P35354PTGS2

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

106Drug interactionsStructured to mechanism, not free text

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Prostaglandin G2, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account